Commercialization
Commercialization funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
China Torch High-Tech Industrial Development Program
A historical reference to China's Torch high-technology industrialisation framework, whose services and applicant routes are administered through separate official notices rather than one universal grant call.
Commercialize Deep Tech in Poland: NCBR STEP Grants for Hardware, Quantum, Robotics, Cleantech and Biotech Ventures
If your company is building a deep-tech product and can show a credible commercialization path, Poland’s STEP calls at NCBR fund industrial-scale R&D that is too expensive for an ordinary startup budget — prototype hardening, testing, certification, and pre-deployment validation. The 2026 Cleantech and Biotech windows are open now.
Deep Tech Commercialisation Grants Europe 2026: How to Win up to €2.5M from the EIC Transition Programme
If you have an EU‑funded research result that is too mature for basic science but not yet ready for investors, you are standing in the most dangerous place in innovation: the gap between lab and market.
Innovate UK Smart Grants Paused: How to Prepare for a Future Opportunity
A practical guide to the paused Innovate UK Smart Grants programme, its last confirmed deadline, baseline fit, and the checks to complete before a new opportunity appears in the Innovation Funding Service.
Kamin Applied Research Program
Funding for Israel-based research groups to move applied research from academia toward industrial commercialization.
NIH NIBIB C3i Validation/Execution 2026/2027: closed-cycle historical reference
A 24-week NIH commercialization training program for investigators and teams with active NIH-funded research from participating Institutes and Centers. The 2026 application cycle closed on July 31, 2026; this page preserves the official cycle details for reference.
NIH PA-27-101: SBIR Phase IIB Strategic Breakthrough Award
The NIH PA-27-101 parent funding opportunity supports previous NIH SBIR and STTR Phase II recipients with a follow-on, commercially-focused Phase IIB award, provided each application includes required 100% third-party matching funds.
NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional): PAR-27-098
A late-stage small business commercialization bridge for U.S. NIH SBIR or STTR Phase II projects that need outsourced technical development, clinical studies, or market-readiness work before full commercialization.
NoFAR Life Sciences Bridging Program
Supports applied life-science and other academic R&D with a commercialization path toward Israeli industry through the Israel Innovation Authority Applied Research in Academia fund.
NSF 26-511: SBIR/STTR Pilot Emphasis on Scientific Instrumentation
Active NSF SBIR/STTR pilot solicitation for U.S. small businesses developing next-generation scientific instrumentation, novel experimental platforms, and related scientific equipment. The next listed full-proposal deadline is November 4, 2026.